210 related articles for article (PubMed ID: 34762666)
1. Role of caveolin-1 as a biomarker for radiation resistance and tumor aggression in lung cancer.
Leiser D; Samanta S; Eley J; Strauss J; Creed M; Kingsbury T; Staats PN; Bhandary B; Chen M; Dukic T; Roy S; Mahmood J; Vujaskovic Z; Shukla HD
PLoS One; 2021; 16(11):e0258951. PubMed ID: 34762666
[TBL] [Abstract][Full Text] [Related]
2. MiR-204 reduces cisplatin resistance in non-small cell lung cancer through suppression of the caveolin-1/AKT/Bad pathway.
Huang G; Lou T; Pan J; Ye Z; Yin Z; Li L; Cheng W; Cao Z
Aging (Albany NY); 2019 Apr; 11(7):2138-2150. PubMed ID: 30981205
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1: a novel prognostic biomarker of radioresistance in cancer.
Mahmood J; Zaveri SR; Murti SC; Alexander AA; Connors CQ; Shukla HD; Vujaskovic Z
Int J Radiat Biol; 2016 Dec; 92(12):747-753. PubMed ID: 27623870
[TBL] [Abstract][Full Text] [Related]
4. Expression of caveolin-1 is correlated with lung adenocarcinoma proliferation, migration, and invasion.
Luan TY; Zhu TN; Cui YJ; Zhang G; Song XJ; Gao DM; Zhang YM; Zhao QL; Liu S; Su TY; Zhao RJ
Med Oncol; 2015 Jul; 32(7):207. PubMed ID: 26094077
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer.
Chatterjee M; Ben-Josef E; Thomas DG; Morgan MA; Zalupski MM; Khan G; Andrew Robinson C; Griffith KA; Chen CS; Ludwig T; Bekaii-Saab T; Chakravarti A; Williams TM
Sci Rep; 2015 Jun; 5():10867. PubMed ID: 26065715
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature.
Bonuccelli G; Casimiro MC; Sotgia F; Wang C; Liu M; Katiyar S; Zhou J; Dew E; Capozza F; Daumer KM; Minetti C; Milliman JN; Alpy F; Rio MC; Tomasetto C; Mercier I; Flomenberg N; Frank PG; Pestell RG; Lisanti MP
Am J Pathol; 2009 May; 174(5):1650-62. PubMed ID: 19395651
[TBL] [Abstract][Full Text] [Related]
7. Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas.
Zhan P; Shen XK; Qian Q; Wang Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK
Oncol Rep; 2012 Apr; 27(4):1072-8. PubMed ID: 22200856
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide promotes cancer cell dedifferentiation by disrupting an Oct4:caveolin-1 complex: A new regulatory mechanism for cancer stem cell formation.
Maiuthed A; Bhummaphan N; Luanpitpong S; Mutirangura A; Aporntewan C; Meeprasert A; Rungrotmongkol T; Rojanasakul Y; Chanvorachote P
J Biol Chem; 2018 Aug; 293(35):13534-13552. PubMed ID: 29986880
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
10. Down expression of
Ling X; Li Y; Qiu F; Lu X; Yang L; Chen J; Li T; Wu D; Xiong H; Su W; Huang D; Chen J; Yang B; Zhao H; Xie C; Zhou Y; Lu J
Aging (Albany NY); 2020 Jan; 12(1):462-480. PubMed ID: 31901898
[No Abstract] [Full Text] [Related]
11. SOX2 Promotes Radioresistance in Non-small Cell Lung Cancer by Regulating Tumor Cells Dedifferentiation.
Wang S; Li Z; Li P; Li L; Liu Y; Feng Y; Li R; Xia S
Int J Med Sci; 2023; 20(6):781-796. PubMed ID: 37213675
[No Abstract] [Full Text] [Related]
12. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
Han Y; Tian H; Chen P; Lin Q
Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
[TBL] [Abstract][Full Text] [Related]
13. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
Mihatsch J; Toulany M; Bareiss PM; Grimm S; Lengerke C; Kehlbach R; Rodemann HP
Radiother Oncol; 2011 Jun; 99(3):300-6. PubMed ID: 21704411
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Gli-1 And Caveolin-1 Expression in the Human Small Cell Lung Cancer.
Wu J; Di D; Zhao C; Pan Q; Liu Y; Zhang X; Zhao X; Chen H
Asian Pac J Cancer Prev; 2018 Feb; 19(2):401-406. PubMed ID: 29479989
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effect of microRNA-1827 on anoikis resistance in lung adenocarcinoma A549 cells via targeting caveolin-1.
Guo X; Wang Z; Sun Q; Sun C; Hua H; Huang Q
Acta Biochim Biophys Sin (Shanghai); 2020 Oct; 52(10):1148-1155. PubMed ID: 33085760
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cells.
Hehlgans S; Eke I; Storch K; Haase M; Baretton GB; Cordes N
Radiother Oncol; 2009 Sep; 92(3):362-70. PubMed ID: 19665245
[TBL] [Abstract][Full Text] [Related]
17. miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164.
Wei T; Cheng S; Fu XN; Feng LJ
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32364222
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts.
Trimmer C; Sotgia F; Whitaker-Menezes D; Balliet RM; Eaton G; Martinez-Outschoorn UE; Pavlides S; Howell A; Iozzo RV; Pestell RG; Scherer PE; Capozza F; Lisanti MP
Cancer Biol Ther; 2011 Feb; 11(4):383-94. PubMed ID: 21150282
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
20. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo.
Ni L; Xu J; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
Eur J Pharmacol; 2021 May; 899():174054. PubMed ID: 33771522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
